Copeptin During a Standardized Psychological Stress Test

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01866137

Acronym

PsyCo

Enrollment

Registered

2013-05-31

Start date

2013-03-31

Completion date

2014-02-28

Last updated

2014-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Keywords

Copeptin, psychological stress, The Trier Social Stress Test (TSST)

Brief summary

The aim of the PsyCo Study is to determine whether psychological Stress has an influence on copeptin levels.

Detailed description

healthy volunteers undergo the TSST and stress hormones as cortisol and copeptin are measured

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

•Aged over 18 years

Exclusion criteria

* Intake of any kind of medication (except birth control pill) * BMI \>30 kg/m2 * Evidence of any acute illness * History of chronic illness * Baseline glucose level \>7 mmol/l Baseline sodium level \<135 mmol/l or \>145 mmol/l

Design outcomes

Primary

Measure	Time frame
Changes in copeptin levels after a psychological stress test in healthy volunteers	30min before, at time point 0, +10, +20, +40, +60 after the psychological stress test

Secondary

Measure	Time frame
Changes in copeptin levels after a psychological stress test in patients with central diabetes insipidus	Timpepoint 0, +10, +20, +40, +60 after the psychological stress test

Countries

Switzerland

Outcome results